MXPA02011174A - Composicion de hidrogel para la liberacion transdermica de medicamento. - Google Patents
Composicion de hidrogel para la liberacion transdermica de medicamento.Info
- Publication number
- MXPA02011174A MXPA02011174A MXPA02011174A MXPA02011174A MXPA02011174A MX PA02011174 A MXPA02011174 A MX PA02011174A MX PA02011174 A MXPA02011174 A MX PA02011174A MX PA02011174 A MXPA02011174 A MX PA02011174A MX PA02011174 A MXPA02011174 A MX PA02011174A
- Authority
- MX
- Mexico
- Prior art keywords
- hydrogel composition
- drug delivery
- transdermal drug
- polymer
- acid polymer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invencion se refiere a una composicion de hidrogel para la liberacion transdermica de farmacos, mas especialmente se refiere a una composicion de hidrogel para la distribucion transdermica de medicamentos, la cual contiene polimeros de acrilato como polimero de acido acrilico, polimero de acido metacrilico, polimero de acrilato de alquilo, polimero de metacrilato de alquilo o copolimeros de estos, como compatibilizadores que hacen posible que mejoradores tanto hidrofilicos como lipofilicos de la permeabilidad sean susceptibles de ser aplicados en la composicion de hidrogel a fin de controlar de manera efectiva la penetracion de la piel por parte de los farmacos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20000026091 | 2000-05-16 | ||
PCT/KR2001/000783 WO2001087276A1 (en) | 2000-05-16 | 2001-05-15 | Hydrogel composition for transdermal drug delivery |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA02011174A true MXPA02011174A (es) | 2004-08-19 |
Family
ID=19668727
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA02011174A MXPA02011174A (es) | 2000-05-16 | 2001-05-15 | Composicion de hidrogel para la liberacion transdermica de medicamento. |
Country Status (13)
Country | Link |
---|---|
US (1) | US20030170295A1 (es) |
EP (1) | EP1282408B1 (es) |
JP (1) | JP4091768B2 (es) |
KR (1) | KR100452972B1 (es) |
CN (1) | CN1239203C (es) |
AT (1) | ATE474563T1 (es) |
AU (2) | AU9521101A (es) |
BR (1) | BR0110843B1 (es) |
CA (1) | CA2409069C (es) |
DE (1) | DE60142616D1 (es) |
MX (1) | MXPA02011174A (es) |
NZ (1) | NZ522532A (es) |
WO (1) | WO2001087276A1 (es) |
Families Citing this family (72)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100452972B1 (ko) * | 2000-05-16 | 2004-10-14 | 주식회사 삼양사 | 경피투여용 하이드로젤 조성물 |
USRE44145E1 (en) | 2000-07-07 | 2013-04-09 | A.V. Topchiev Institute Of Petrochemical Synthesis | Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties |
US20050215727A1 (en) | 2001-05-01 | 2005-09-29 | Corium | Water-absorbent adhesive compositions and associated methods of manufacture and use |
US8541021B2 (en) | 2001-05-01 | 2013-09-24 | A.V. Topchiev Institute Of Petrochemical Synthesis | Hydrogel compositions demonstrating phase separation on contact with aqueous media |
US8206738B2 (en) | 2001-05-01 | 2012-06-26 | Corium International, Inc. | Hydrogel compositions with an erodible backing member |
US8840918B2 (en) | 2001-05-01 | 2014-09-23 | A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences | Hydrogel compositions for tooth whitening |
US8728445B2 (en) | 2001-05-01 | 2014-05-20 | A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Sciences | Hydrogel Compositions |
CA2446060A1 (en) * | 2001-05-07 | 2002-11-14 | Corium International | Compositions and delivery systems for administration of a local anesthetic agent |
DE10141650C1 (de) | 2001-08-24 | 2002-11-28 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen |
KR100433363B1 (ko) * | 2002-04-15 | 2004-05-28 | 주식회사 동구제약 | 아시클로버함유 외용필름형성 하이드로겔 제제 |
US7645462B2 (en) * | 2002-08-27 | 2010-01-12 | 3T Herbtech, Inc. | Acupoint patch |
JP5137286B2 (ja) * | 2003-06-10 | 2013-02-06 | 帝國製薬株式会社 | フェンタニル含有口腔粘膜貼付剤 |
US20070021404A1 (en) * | 2003-06-24 | 2007-01-25 | Dan Peters | Novel aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
RU2351315C2 (ru) * | 2003-07-24 | 2009-04-10 | Смитклайн Бичам Корпорейшн | Пленки, растворяющиеся в полости рта |
US8658201B2 (en) | 2004-01-30 | 2014-02-25 | Corium International, Inc. | Rapidly dissolving film for delivery of an active agent |
WO2005112984A2 (en) * | 2004-05-13 | 2005-12-01 | Alza Corporation | Apparatus and method for transdermal delivery of parathyroid hormone agents |
US20060029654A1 (en) * | 2004-08-04 | 2006-02-09 | Cassel R D | Analgesic patch for sports injury rehabilitation medicine and method to alleviate pain |
CN101039706A (zh) | 2004-08-05 | 2007-09-19 | 考里安国际公司 | 粘合剂组合物 |
US8252320B2 (en) | 2004-10-21 | 2012-08-28 | Durect Corporation | Transdermal delivery system for sufentanil |
ATE551995T1 (de) | 2004-10-21 | 2012-04-15 | Durect Corp | Transdermale abgabesysteme |
DK1877509T3 (da) | 2005-03-17 | 2012-01-23 | Pharmafilm S R L | Vandigt polymersystem til trykfølsom klæbemiddelmatrixfremstilling |
TWI419717B (zh) * | 2005-06-17 | 2013-12-21 | Altea Therapeutics Corp | 滲透傳送系統及其使用方法 |
US20070065494A1 (en) * | 2005-08-03 | 2007-03-22 | Watson Laboratories, Inc. | Formulations and Methods for Enhancing the Transdermal Penetration of a Drug |
NZ568313A (en) * | 2005-11-21 | 2011-11-25 | Schering Plough Ltd | Pharmaceutical compositions comprising buprenorphine |
CN101442987A (zh) * | 2005-12-14 | 2009-05-27 | 扎尔斯制药公司 | 喷雾制剂和皮肤给药方法 |
JP5285279B2 (ja) * | 2005-12-28 | 2013-09-11 | 久光製薬株式会社 | 経皮吸収型製剤 |
JP2007320886A (ja) * | 2006-05-31 | 2007-12-13 | Isp Japan Kk | 含水ゲル状シート剤及びその製造方法 |
KR100809488B1 (ko) * | 2006-07-19 | 2008-03-03 | 도용진 | 시이트형 하이드로겔 팩의 조성물 및 그를 이용한 시이트형 하이드로겔 팩의 제조방법 |
WO2008070118A1 (en) | 2006-12-05 | 2008-06-12 | Landec Corporation | Drug delivery |
CA2702096A1 (en) * | 2007-10-10 | 2009-04-16 | Benz Research And Development Corp. | Hydrogel with high water content and stability |
KR20090101579A (ko) * | 2008-03-24 | 2009-09-29 | 조선대학교산학협력단 | 펜타닐을 함유한 경피 흡수제 |
US20100055161A1 (en) * | 2008-08-27 | 2010-03-04 | Dong June Ahn | Hydrogel face mask for delivering skin care agents |
WO2010064988A1 (en) * | 2008-12-04 | 2010-06-10 | Swedish Pharma Ab | Bioadhesive patch |
AU2010204986B2 (en) | 2009-01-14 | 2016-06-02 | Corium International, Inc. | Transdermal administration of tamsulosin |
CN102048679B (zh) * | 2009-10-30 | 2013-01-30 | 陕西麦科奥特生物科技有限公司 | 含有西罗多辛的透皮吸收制剂及其制备方法与药物应用 |
PL2512446T3 (pl) * | 2009-12-16 | 2015-08-31 | Shasun Pharmaceuticals Ltd | Kompozycja transdermalnego hydrożelu z deksibuprofenem |
DE102010038312A1 (de) * | 2010-07-23 | 2012-01-26 | Beiersdorf Ag | Optimierte Hydrogel-Matrixsysteme mit einem Gehalt an Emulgatoren |
JP2014515365A (ja) * | 2011-05-26 | 2014-06-30 | ノバルティス アーゲー | 生理学的活性剤の経皮投与のための組成物 |
WO2013112947A1 (en) * | 2012-01-26 | 2013-08-01 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
ES2885523T3 (es) | 2011-11-23 | 2021-12-14 | Therapeuticsmd Inc | Formulaciones y terapias de reposición hormonal de combinación naturales |
JP2015516441A (ja) * | 2012-05-18 | 2015-06-11 | ルオダ ファーマ ピーティーワイ リミテッド | 液体配合剤 |
FR2991175B1 (fr) * | 2012-06-01 | 2014-12-19 | Galderma Res & Dev | Compositions pharmaceutiques topiques de type emulsion h/e contenant un retinoide |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20130338122A1 (en) * | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10046079B2 (en) * | 2013-03-15 | 2018-08-14 | Materials Modification Inc. | Clay composites and their applications |
JP6114401B2 (ja) | 2013-10-31 | 2017-04-12 | 久光製薬株式会社 | アジュバント組成物、これを含むアジュバント製剤、及びキット |
AU2015264003A1 (en) | 2014-05-22 | 2016-11-17 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
RU2700032C2 (ru) * | 2014-08-25 | 2019-09-12 | ХЕНКЕЛЬ АйПи ЭНД ХОЛДИНГ ГМБХ | Акриловые полимеры и их применение при трансдермальной доставке лекарственного средства |
LT3265140T (lt) | 2015-03-02 | 2021-09-27 | Medlab Clinical U.S., Inc. | Transmukozinės ir transderminės pristatymo sistemos |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
TWI687239B (zh) * | 2015-10-26 | 2020-03-11 | 日商久光製藥股份有限公司 | 貼附劑 |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
WO2017173071A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
KR101786914B1 (ko) * | 2017-01-31 | 2017-11-15 | 주식회사 삼양사 | 피부 리프팅 또는 탄력 개선을 위한 점착성 탄력 밴드 |
GB201709141D0 (en) | 2017-06-08 | 2017-07-26 | Klaria Pharma Holding Ab | Pharmaceutical formulation |
US10821075B1 (en) | 2017-07-12 | 2020-11-03 | James Blanchard | Compositions for topical application of a medicaments onto a mammalian body surface |
CN109939065B (zh) * | 2018-08-10 | 2021-08-03 | 上海瑞凝生物科技有限公司 | 医用水凝胶 |
US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
FR3108841B1 (fr) * | 2020-04-06 | 2023-11-03 | Algotherapeutix | Composition pharmaceutique topique sous forme de gel aqueux comprenant au moins de l’amitriptyline |
CN112961641B (zh) * | 2021-03-16 | 2022-05-20 | 美瑞新材料股份有限公司 | Pvc接枝改性的水性聚氨酯胶粘剂及其制备方法和应用 |
KR102554869B1 (ko) | 2021-03-19 | 2023-07-12 | 롯데정밀화학 주식회사 | 친수성 활성성분의 경피 투과성이 개선된 경피 전달용 필름형성 조성물 및 이 조성물을 이용한 경피 전달용 필름의 제조방법 |
CN113171310B (zh) * | 2021-04-21 | 2023-01-17 | 上海宜侬生物科技有限公司 | 化妆品用双水相体系 |
WO2022249748A1 (ja) * | 2021-05-24 | 2022-12-01 | 住友精化株式会社 | ゲル状組成物 |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1165240A (en) | 1980-07-09 | 1984-04-10 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions |
US4543371A (en) * | 1981-03-05 | 1985-09-24 | Syntex (U.S.A.) Inc. | Polymeric compositions and hydrogels formed therefrom |
US4482533A (en) * | 1982-01-11 | 1984-11-13 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing propranolol |
US4537776A (en) * | 1983-06-21 | 1985-08-27 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone |
US4593053A (en) * | 1984-12-07 | 1986-06-03 | Medtronic, Inc. | Hydrophilic pressure sensitive biomedical adhesive composition |
JPS62123112A (ja) * | 1985-11-22 | 1987-06-04 | Sunstar Inc | 軟膏基剤 |
EP0280737B1 (en) * | 1986-08-20 | 1991-12-11 | Teikoku Seiyaku Co., Ltd. | Steroidal drug-containing preparation for external use |
US4863970A (en) * | 1986-11-14 | 1989-09-05 | Theratech, Inc. | Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols |
DE3643987A1 (de) * | 1986-12-22 | 1988-06-23 | Lohmann Therapie Syst Lts | Basische, wirkstoffdurchlaessige haftklebende polymermasse, insbesondere zum einsatz mit basischen wirkstoffen, verfahren zu ihrer herstellung und ihre verwendung |
US5925372A (en) * | 1987-12-16 | 1999-07-20 | Novartis Corporation | Mixed solvent mutually enhanced transdermal therapeutic system |
US5656286A (en) * | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
US5474783A (en) * | 1988-03-04 | 1995-12-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
DE69010076T2 (de) * | 1989-05-25 | 1994-12-08 | Takeda Chemical Industries Ltd | Transdermales therapeutisches Mittel. |
US5252334A (en) * | 1989-09-08 | 1993-10-12 | Cygnus Therapeutic Systems | Solid matrix system for transdermal drug delivery |
EP0516026A1 (en) | 1991-05-28 | 1992-12-02 | Takeda Chemical Industries, Ltd. | Hydrogel and method of producing same |
US5238933A (en) * | 1991-10-28 | 1993-08-24 | Sri International | Skin permeation enhancer compositions |
US5698589A (en) | 1993-06-01 | 1997-12-16 | International Medical Innovations, Inc. | Water-based topical cream containing nitroglycerin and method of preparation and use thereof |
US5614586A (en) * | 1994-04-06 | 1997-03-25 | Graphic Controls Corporation | Polyacrylate and Polymethacrylate ester based hydrogel adhesives |
US5614210A (en) * | 1995-03-31 | 1997-03-25 | Minnesota Mining And Manufacturing Company | Transdermal device for the delivery of alfuzosin |
US5698217A (en) * | 1995-05-31 | 1997-12-16 | Minnesota Mining And Manufacturing Company | Transdermal drug delivery device containing a desiccant |
DE19617716A1 (de) * | 1996-05-03 | 1997-11-06 | Basf Ag | In wäßriger Lösung redispergierbare Polymerpulver |
TW411277B (en) * | 1996-05-13 | 2000-11-11 | Hisamitsu Pharmaceutical Co | Percutaneous tape preparation containing fentanyl |
HUP9601443A3 (en) | 1996-05-29 | 1999-03-29 | Panacea Biotec Ltd | Injectable analgetic pharmaceutical compositions for intramuscular use containing nimesulid, and process for producing them |
US6007837A (en) * | 1996-07-03 | 1999-12-28 | Alza Corporation | Drug delivery devices and process of manufacture |
DE19631084A1 (de) * | 1996-08-01 | 1998-02-05 | Basf Ag | Verwendung von (Meth)acrylsäure-Copolymeren zur Erhöhung der Permeabilität der Schleimhaut |
KR19980067255A (ko) * | 1997-01-31 | 1998-10-15 | 이웅열 | 친수성 약물의 경피투여시스템 |
US5968547A (en) * | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
US6132761A (en) * | 1997-09-05 | 2000-10-17 | Nitto Denko Corporation | Percutaneous absorption preparation |
US20020012694A1 (en) | 1997-09-17 | 2002-01-31 | Alfred J. Moo-Young | Transdermal administration of ment |
EP1021204B1 (en) * | 1997-09-26 | 2005-12-28 | Noven Pharmaceuticals, Inc. | Bioadhesive compositions and methods for topical administration of active agents |
US6039977A (en) * | 1997-12-09 | 2000-03-21 | Alza Corporation | Pharmaceutical hydrogel formulations, and associated drug delivery devices and methods |
FR2776191B1 (fr) * | 1998-03-23 | 2002-05-31 | Theramex | Composition hormonale topique a effet systemique |
KR100452972B1 (ko) * | 2000-05-16 | 2004-10-14 | 주식회사 삼양사 | 경피투여용 하이드로젤 조성물 |
-
2001
- 2001-05-14 KR KR10-2001-0026202A patent/KR100452972B1/ko active IP Right Grant
- 2001-05-15 CA CA002409069A patent/CA2409069C/en not_active Expired - Fee Related
- 2001-05-15 NZ NZ522532A patent/NZ522532A/en not_active IP Right Cessation
- 2001-05-15 DE DE60142616T patent/DE60142616D1/de not_active Expired - Lifetime
- 2001-05-15 BR BRPI0110843-3B1A patent/BR0110843B1/pt not_active IP Right Cessation
- 2001-05-15 CN CNB018095860A patent/CN1239203C/zh not_active Expired - Fee Related
- 2001-05-15 US US10/276,498 patent/US20030170295A1/en not_active Abandoned
- 2001-05-15 EP EP01977953A patent/EP1282408B1/en not_active Expired - Lifetime
- 2001-05-15 AU AU9521101A patent/AU9521101A/xx active Pending
- 2001-05-15 WO PCT/KR2001/000783 patent/WO2001087276A1/en active IP Right Grant
- 2001-05-15 MX MXPA02011174A patent/MXPA02011174A/es active IP Right Grant
- 2001-05-15 JP JP2001583744A patent/JP4091768B2/ja not_active Expired - Fee Related
- 2001-05-15 AU AU2001295211A patent/AU2001295211B2/en not_active Ceased
- 2001-05-15 AT AT01977953T patent/ATE474563T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE60142616D1 (de) | 2010-09-02 |
EP1282408A1 (en) | 2003-02-12 |
JP4091768B2 (ja) | 2008-05-28 |
NZ522532A (en) | 2005-04-29 |
CA2409069C (en) | 2008-09-09 |
ATE474563T1 (de) | 2010-08-15 |
CN1429102A (zh) | 2003-07-09 |
CN1239203C (zh) | 2006-02-01 |
AU2001295211B2 (en) | 2004-10-28 |
WO2001087276A1 (en) | 2001-11-22 |
AU9521101A (en) | 2001-11-26 |
JP2003533471A (ja) | 2003-11-11 |
EP1282408B1 (en) | 2010-07-21 |
KR100452972B1 (ko) | 2004-10-14 |
BR0110843A (pt) | 2003-12-30 |
KR20020002199A (ko) | 2002-01-09 |
US20030170295A1 (en) | 2003-09-11 |
BR0110843B1 (pt) | 2013-11-26 |
CA2409069A1 (en) | 2001-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU9521101A (en) | Hydrogel composition for transdermal drug delivery | |
MY113685A (en) | Transdermal device for the delivery of flurbiprofen | |
EP2153827A3 (en) | Composition for the Transdermal Delivery of Fentanyl | |
AR111679A2 (es) | Formulación farmacéutica de liberación controlada, procesos, usos, método | |
WO2006041911A3 (en) | Device transdermal administration of drugs including acrylic polymers | |
DE60118933D1 (de) | Matrix zur aufnahme von arzneimitteln | |
ATE494010T1 (de) | Zusammensetzungen zur abgabe von therapeutika und anderen materialien und verfahren zu ihrer herstellung und verwendung | |
JP2004513890A5 (es) | ||
DE69530177D1 (de) | Als löslichkeit-steigernde gebrauchte polyvinylpyrrolidon enthaltende transdermale vorrichtung | |
AR047540A1 (es) | Particulados | |
PT1061900E (pt) | Composicoes e metodos para libertacao de uma droga | |
NZ505431A (en) | Solid thermoformable controlled-release pharmaceutical composition | |
MXPA06012780A (es) | Polimeros a base de acrilico y celulosa y el uso de los mismos para el tratamiento de enfermedades infecciosas. | |
ATE471954T1 (de) | Teilneutralisiertes anionisches (meth)acrylat- copolymer | |
AU2002363885A1 (en) | Adhesive and binding agent for dermal or transdermal treatment systems | |
WO2002024157A3 (en) | Acryl adhesive useful in transdermal drug delivery systems | |
WO2008105038A1 (ja) | 抗真菌症用貼付剤 | |
MA26777A1 (fr) | Inhibiteurs d'aminotransferase dependante d'aminoacide en chaine ramifiee et leur usage dans le traitement de la retinopathie diabetique. | |
WO2002060417A8 (de) | Lagerstabiles haft- und bindemittel für pharmazeutische anwendungen | |
RS20050809A (en) | Pharmaceutical compozition in the form of a hydrogel for transdermal administration of active substances | |
ATE442838T1 (de) | Verfahren zur herstellung einer festen pharmazeutischen zusammensetzung | |
UA49635A (uk) | Спосіб одержання фізіологічно активних полімерів | |
CY1114064T1 (el) | Συνθεση για τη διαδερμικη χορηγηση της φεντανυλης | |
KR860003010A (ko) | 경피 투여형 약제 | |
GR1005122B (el) | Μεθοδος κατακρατησης και εξουδετερωσης των πολεμικων βιολογικων και χημικων παραγοντων με την χρησιμοποιηση πολυμερισμενης νιτροζυλοαιμοσφαιρινης-αιμης ως φραγμου του δερματος και του οφθαλμου |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
GB | Transfer or rights | ||
HC | Change of company name or juridical status |